Skip to main content
Premium Trial:

Request an Annual Quote

John Berriman

Premium
Solexa co-founder John Berriman has become chairman of Belgian biomarker company Pronota, the company said last week. Berriman is also chairman of Algeta and a director at MicroMet, Ablynx, and Oxxon Therapeutics.
 
Previously, he was a director at Abingworth Management, after working at Celltech Group. In addition, he was a director at Solexa, Epigenomics, Alnylam, and XCounter, and chairman of Chroma Therapeutics.
 
Berriman holds a chemical engineering degree from the University of Cambridge and an MBA from the London Business School.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.